AZ announces US fast track designation for IL-5 inhibitor Fasenra

8th November 2021 Uncategorised 0

Designation granted for the treatment of eosinophilic gastritis with or without eosinophilic gastroenteritis

More: AZ announces US fast track designation for IL-5 inhibitor Fasenra
Source: News